The Role of Strength Training in Preserving Muscle Mass During Weight Loss Plateaus on GLP-1 Therapy

Strength training is essential for maintaining muscle mass during weight loss plateaus on GLP-1 therapy, as it counteracts the muscle loss often associated with calorie deficit and enhances metabolic health.

Introduction to GLP-1 Therapy and Weight Loss Plateaus

GLP-1 receptor agonists, such as liraglutide and semaglutide, have shown significant efficacy in promoting weight loss by reducing appetite and improving glycemic control (Jastreboff 2023 NEJM). However, weight loss plateaus are common, often due to metabolic adaptations and reduced energy expenditure.

The Impact of GLP-1 Therapy on Muscle Mass

While GLP-1 therapy promotes fat loss, it can also lead to reductions in lean body mass, particularly if dietary protein intake is insufficient (Coskun 2022). This muscle loss can hinder metabolic rate and overall health.

Strength Training as a Countermeasure

Strength training stimulates muscle protein synthesis and increases muscle mass, which can help offset the muscle loss associated with GLP-1 therapy (Finan 2015). Incorporating resistance exercises ensures that weight loss primarily targets fat rather than muscle.

Mechanisms Behind Muscle Preservation

Strength training enhances muscle protein synthesis, improves insulin sensitivity, and increases resting metabolic rate. These mechanisms collectively support muscle preservation during weight loss plateaus (STEP trial).

Practical Recommendations for Incorporating Strength Training

To maximize muscle preservation, individuals on GLP-1 therapy should engage in regular strength training sessions, focusing on major muscle groups. Adequate protein intake and progressive overload are crucial for optimizing results (SURMOUNT trial).

Conclusion

Strength training plays a pivotal role in maintaining muscle mass during weight loss plateaus on GLP-1 therapy, supporting both metabolic health and long-term weight management.